Jillian Cotter
Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonia | 16 | 2026 | 635 | 4.880 |
Why?
| | Community-Acquired Infections | 12 | 2026 | 179 | 4.530 |
Why?
| | Anti-Bacterial Agents | 16 | 2026 | 1942 | 3.080 |
Why?
| | Hospitals, Pediatric | 16 | 2025 | 561 | 2.400 |
Why?
| | Clostridium Infections | 2 | 2024 | 75 | 1.320 |
Why?
| | Respiratory Tract Infections | 6 | 2025 | 403 | 1.140 |
Why?
| | Child | 46 | 2026 | 22693 | 1.130 |
Why?
| | Hospitalization | 13 | 2026 | 2475 | 1.120 |
Why?
| | Feces | 3 | 2023 | 496 | 1.050 |
Why?
| | Length of Stay | 7 | 2024 | 1358 | 1.020 |
Why?
| | Infant | 24 | 2026 | 10114 | 0.870 |
Why?
| | Communicable Diseases | 3 | 2023 | 166 | 0.840 |
Why?
| | Gastroenteritis | 2 | 2023 | 63 | 0.820 |
Why?
| | Catheterization, Peripheral | 1 | 2025 | 116 | 0.810 |
Why?
| | Child, Preschool | 21 | 2026 | 11913 | 0.810 |
Why?
| | Soft Tissue Infections | 2 | 2021 | 42 | 0.780 |
Why?
| | Multiplex Polymerase Chain Reaction | 2 | 2021 | 56 | 0.780 |
Why?
| | Retrospective Studies | 27 | 2026 | 17438 | 0.770 |
Why?
| | Administration, Intravenous | 4 | 2025 | 172 | 0.770 |
Why?
| | Multicenter Studies as Topic | 1 | 2025 | 417 | 0.760 |
Why?
| | Diagnostic Tests, Routine | 1 | 2024 | 109 | 0.750 |
Why?
| | Asthma | 4 | 2024 | 1800 | 0.750 |
Why?
| | Administration, Oral | 4 | 2026 | 872 | 0.720 |
Why?
| | Urinary Tract Infections | 2 | 2024 | 209 | 0.720 |
Why?
| | Antimicrobial Stewardship | 2 | 2021 | 136 | 0.680 |
Why?
| | Pneumonia, Bacterial | 1 | 2022 | 114 | 0.670 |
Why?
| | Cholangitis, Sclerosing | 2 | 2018 | 56 | 0.630 |
Why?
| | Respiratory Insufficiency | 1 | 2024 | 330 | 0.610 |
Why?
| | Dexamethasone | 2 | 2019 | 368 | 0.610 |
Why?
| | Diarrhea | 2 | 2023 | 190 | 0.610 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2019 | 27 | 0.600 |
Why?
| | Patient Readmission | 6 | 2026 | 778 | 0.600 |
Why?
| | Prednisone | 2 | 2019 | 229 | 0.570 |
Why?
| | Healthcare Disparities | 1 | 2026 | 733 | 0.560 |
Why?
| | Liver Function Tests | 2 | 2018 | 103 | 0.550 |
Why?
| | Research Design | 1 | 2025 | 1143 | 0.550 |
Why?
| | Child, Hospitalized | 3 | 2024 | 52 | 0.550 |
Why?
| | Patient Care | 1 | 2019 | 120 | 0.540 |
Why?
| | Pediatricians | 1 | 2019 | 120 | 0.540 |
Why?
| | Humans | 60 | 2026 | 146342 | 0.530 |
Why?
| | Gastrointestinal Diseases | 1 | 2020 | 220 | 0.520 |
Why?
| | Liver Cirrhosis | 1 | 2018 | 278 | 0.450 |
Why?
| | Practice Patterns, Physicians' | 3 | 2025 | 1408 | 0.440 |
Why?
| | Amoxicillin | 2 | 2025 | 35 | 0.430 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 568 | 0.410 |
Why?
| | Critical Pathways | 2 | 2025 | 104 | 0.390 |
Why?
| | Emergency Service, Hospital | 9 | 2025 | 2363 | 0.390 |
Why?
| | Male | 25 | 2026 | 73396 | 0.380 |
Why?
| | Cross-Sectional Studies | 9 | 2026 | 5899 | 0.380 |
Why?
| | Propensity Score | 3 | 2024 | 376 | 0.380 |
Why?
| | Female | 23 | 2026 | 79499 | 0.340 |
Why?
| | Adolescent | 13 | 2025 | 22557 | 0.330 |
Why?
| | Prospective Studies | 8 | 2023 | 8123 | 0.310 |
Why?
| | Intervertebral Disc Degeneration | 2 | 2014 | 33 | 0.290 |
Why?
| | Patient Safety | 2 | 2019 | 352 | 0.230 |
Why?
| | Influenza, Human | 2 | 2023 | 640 | 0.230 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2025 | 48 | 0.220 |
Why?
| | Antigens, Bacterial | 1 | 2025 | 125 | 0.210 |
Why?
| | Transforming Growth Factor beta3 | 1 | 2014 | 15 | 0.210 |
Why?
| | Diskectomy | 1 | 2014 | 23 | 0.210 |
Why?
| | Primary Myelofibrosis | 1 | 2014 | 8 | 0.200 |
Why?
| | Tennis | 1 | 2014 | 5 | 0.200 |
Why?
| | Thrombocythemia, Essential | 1 | 2014 | 7 | 0.200 |
Why?
| | Polycythemia Vera | 1 | 2014 | 9 | 0.200 |
Why?
| | Ascorbic Acid Deficiency | 1 | 2024 | 10 | 0.200 |
Why?
| | Phlebotomy | 1 | 2024 | 21 | 0.200 |
Why?
| | Intervertebral Disc | 1 | 2014 | 35 | 0.200 |
Why?
| | Scurvy | 1 | 2024 | 18 | 0.200 |
Why?
| | Cell Survival | 2 | 2014 | 1105 | 0.200 |
Why?
| | Cannula | 1 | 2024 | 30 | 0.200 |
Why?
| | Treatment Failure | 1 | 2024 | 361 | 0.190 |
Why?
| | Inpatients | 2 | 2025 | 540 | 0.190 |
Why?
| | Matrix Attachment Region Binding Proteins | 1 | 2013 | 6 | 0.190 |
Why?
| | Hypertension, Portal | 1 | 2014 | 66 | 0.190 |
Why?
| | Streptococcus pneumoniae | 1 | 2025 | 187 | 0.190 |
Why?
| | Hospitals, Community | 1 | 2024 | 68 | 0.190 |
Why?
| | Spinal Fractures | 1 | 2014 | 81 | 0.190 |
Why?
| | Diagnostic Imaging | 1 | 2025 | 340 | 0.180 |
Why?
| | Portal Vein | 1 | 2014 | 123 | 0.180 |
Why?
| | Low Back Pain | 1 | 2014 | 109 | 0.180 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2023 | 83 | 0.180 |
Why?
| | Seizures, Febrile | 1 | 2022 | 23 | 0.180 |
Why?
| | Femur Neck | 1 | 2012 | 64 | 0.180 |
Why?
| | Data Collection | 1 | 2025 | 650 | 0.170 |
Why?
| | Lumbar Vertebrae | 1 | 2014 | 260 | 0.170 |
Why?
| | Curriculum | 2 | 2019 | 1079 | 0.170 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2023 | 141 | 0.170 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2024 | 190 | 0.170 |
Why?
| | Treatment Outcome | 5 | 2024 | 11821 | 0.170 |
Why?
| | Intracranial Aneurysm | 2 | 2008 | 105 | 0.160 |
Why?
| | Viruses | 1 | 2023 | 165 | 0.160 |
Why?
| | Fever | 1 | 2022 | 322 | 0.160 |
Why?
| | Hospital Medicine | 1 | 2022 | 101 | 0.160 |
Why?
| | Clinical Competence | 2 | 2019 | 1272 | 0.160 |
Why?
| | Aftercare | 1 | 2022 | 225 | 0.160 |
Why?
| | Virus Diseases | 1 | 2023 | 219 | 0.160 |
Why?
| | Pseudomonas Infections | 1 | 2022 | 229 | 0.160 |
Why?
| | Skin Diseases, Infectious | 1 | 2020 | 14 | 0.160 |
Why?
| | Infant, Newborn | 4 | 2025 | 6460 | 0.150 |
Why?
| | Endpoint Determination | 1 | 2020 | 84 | 0.150 |
Why?
| | Blood Culture | 1 | 2020 | 27 | 0.150 |
Why?
| | Mentoring | 1 | 2022 | 166 | 0.150 |
Why?
| | Severity of Illness Index | 4 | 2022 | 2921 | 0.150 |
Why?
| | Pulmonologists | 1 | 2019 | 14 | 0.150 |
Why?
| | Mandatory Reporting | 1 | 2019 | 45 | 0.150 |
Why?
| | Hematopoietic Stem Cells | 1 | 2013 | 432 | 0.150 |
Why?
| | Bone and Bones | 1 | 2012 | 319 | 0.150 |
Why?
| | Symptom Flare Up | 1 | 2019 | 37 | 0.150 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 253 | 0.140 |
Why?
| | Rotator Cuff Injuries | 1 | 2019 | 79 | 0.140 |
Why?
| | Drug Substitution | 1 | 2019 | 62 | 0.140 |
Why?
| | Competency-Based Education | 1 | 2019 | 83 | 0.140 |
Why?
| | Respiration, Artificial | 1 | 2024 | 711 | 0.140 |
Why?
| | Immunocompromised Host | 1 | 2019 | 201 | 0.140 |
Why?
| | Biliary Tract | 1 | 2018 | 13 | 0.130 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 1 | 2018 | 24 | 0.130 |
Why?
| | Otitis Media | 1 | 2020 | 178 | 0.130 |
Why?
| | Arthroscopy | 1 | 2019 | 281 | 0.130 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 790 | 0.130 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2008 | 1224 | 0.130 |
Why?
| | Consensus | 1 | 2019 | 467 | 0.130 |
Why?
| | Polymerase Chain Reaction | 1 | 2020 | 1031 | 0.120 |
Why?
| | Time-to-Treatment | 1 | 2019 | 257 | 0.120 |
Why?
| | Universities | 1 | 2019 | 451 | 0.120 |
Why?
| | Pandemics | 2 | 2023 | 1707 | 0.120 |
Why?
| | Quality Improvement | 1 | 2025 | 1354 | 0.120 |
Why?
| | Preleukemia | 1 | 2015 | 2 | 0.110 |
Why?
| | Sepsis | 1 | 2022 | 669 | 0.110 |
Why?
| | Patient Discharge | 1 | 2022 | 997 | 0.110 |
Why?
| | Schools | 1 | 2018 | 436 | 0.110 |
Why?
| | Anti-Inflammatory Agents | 1 | 2019 | 474 | 0.110 |
Why?
| | Incidence | 2 | 2020 | 2936 | 0.110 |
Why?
| | Colorado | 3 | 2020 | 4595 | 0.110 |
Why?
| | Self Report | 1 | 2019 | 870 | 0.110 |
Why?
| | Hospitalists | 1 | 2019 | 288 | 0.100 |
Why?
| | Quality of Life | 2 | 2023 | 3200 | 0.100 |
Why?
| | Lumbosacral Region | 1 | 2013 | 58 | 0.100 |
Why?
| | Trans-Activators | 1 | 2015 | 372 | 0.100 |
Why?
| | Prevalence | 1 | 2020 | 2861 | 0.090 |
Why?
| | Communication | 1 | 2019 | 980 | 0.090 |
Why?
| | Polymorphism, Genetic | 2 | 2013 | 612 | 0.090 |
Why?
| | Cystic Fibrosis | 1 | 2022 | 1164 | 0.090 |
Why?
| | Medical Errors | 1 | 2013 | 124 | 0.090 |
Why?
| | Intraoperative Complications | 1 | 2013 | 157 | 0.090 |
Why?
| | Proto-Oncogene Proteins | 1 | 2015 | 616 | 0.090 |
Why?
| | Spine | 1 | 2013 | 184 | 0.090 |
Why?
| | Age Factors | 1 | 2019 | 3347 | 0.090 |
Why?
| | Internship and Residency | 2 | 2019 | 1281 | 0.090 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 769 | 0.090 |
Why?
| | Inflammation | 2 | 2008 | 2919 | 0.080 |
Why?
| | Liver Transplantation | 1 | 2017 | 751 | 0.080 |
Why?
| | Pediatrics | 1 | 2018 | 1124 | 0.080 |
Why?
| | Ambulatory Care | 2 | 2025 | 628 | 0.080 |
Why?
| | United States | 5 | 2025 | 16136 | 0.070 |
Why?
| | Surveys and Questionnaires | 2 | 2019 | 6073 | 0.070 |
Why?
| | Liver | 1 | 2018 | 1864 | 0.070 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2015 | 702 | 0.070 |
Why?
| | Primary Health Care | 1 | 2018 | 1776 | 0.070 |
Why?
| | Postoperative Complications | 1 | 2019 | 3034 | 0.060 |
Why?
| | Biomarkers | 1 | 2018 | 4340 | 0.060 |
Why?
| | Serogroup | 1 | 2025 | 46 | 0.060 |
Why?
| | Disease Progression | 3 | 2019 | 2867 | 0.050 |
Why?
| | Inflammation Mediators | 1 | 2008 | 508 | 0.050 |
Why?
| | Azithromycin | 1 | 2025 | 101 | 0.050 |
Why?
| | Aggrecans | 1 | 2014 | 15 | 0.050 |
Why?
| | Organ Culture Techniques | 1 | 2014 | 150 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2488 | 0.050 |
Why?
| | Proteoglycans | 1 | 2014 | 111 | 0.050 |
Why?
| | Fracture Healing | 1 | 2014 | 92 | 0.050 |
Why?
| | Penicillins | 1 | 2023 | 65 | 0.050 |
Why?
| | Uncertainty | 1 | 2024 | 145 | 0.050 |
Why?
| | Microbial Sensitivity Tests | 1 | 2024 | 367 | 0.050 |
Why?
| | Patient Acuity | 1 | 2022 | 46 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2024 | 183 | 0.050 |
Why?
| | Bone Development | 1 | 2012 | 52 | 0.040 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2013 | 109 | 0.040 |
Why?
| | Cell Polarity | 1 | 2013 | 138 | 0.040 |
Why?
| | Tensile Strength | 1 | 2012 | 98 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2013 | 157 | 0.040 |
Why?
| | Cattle | 1 | 2014 | 940 | 0.040 |
Why?
| | Cadaver | 1 | 2012 | 304 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2024 | 3926 | 0.040 |
Why?
| | Cell Lineage | 1 | 2013 | 377 | 0.040 |
Why?
| | Goals | 1 | 2022 | 187 | 0.040 |
Why?
| | Outpatients | 1 | 2024 | 440 | 0.040 |
Why?
| | Benchmarking | 1 | 2022 | 193 | 0.040 |
Why?
| | Mentors | 1 | 2022 | 217 | 0.040 |
Why?
| | Peer Group | 1 | 2022 | 251 | 0.040 |
Why?
| | ROC Curve | 1 | 2022 | 617 | 0.040 |
Why?
| | Medicaid | 1 | 2024 | 477 | 0.040 |
Why?
| | Absenteeism | 1 | 2020 | 51 | 0.040 |
Why?
| | Stress, Mechanical | 1 | 2012 | 497 | 0.040 |
Why?
| | Social Determinants of Health | 1 | 2024 | 317 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 486 | 0.040 |
Why?
| | Regression Analysis | 1 | 2012 | 999 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2014 | 883 | 0.040 |
Why?
| | Pseudomonas aeruginosa | 1 | 2022 | 392 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2013 | 597 | 0.040 |
Why?
| | Guideline Adherence | 1 | 2023 | 594 | 0.040 |
Why?
| | Hospitals | 1 | 2024 | 738 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2012 | 874 | 0.030 |
Why?
| | Bone Density | 1 | 2012 | 494 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2013 | 902 | 0.030 |
Why?
| | Anti-Infective Agents | 1 | 2020 | 234 | 0.030 |
Why?
| | Bacteremia | 1 | 2020 | 218 | 0.030 |
Why?
| | Chronic Disease | 1 | 2023 | 1827 | 0.030 |
Why?
| | Shoulder Joint | 1 | 2019 | 199 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2019 | 282 | 0.030 |
Why?
| | Acute Disease | 1 | 2020 | 1038 | 0.030 |
Why?
| | Range of Motion, Articular | 1 | 2019 | 446 | 0.030 |
Why?
| | Japan | 1 | 2017 | 149 | 0.030 |
Why?
| | Adult | 4 | 2019 | 41087 | 0.030 |
Why?
| | Biopsy, Needle | 1 | 2017 | 183 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2013 | 1130 | 0.030 |
Why?
| | Internationality | 1 | 2017 | 156 | 0.030 |
Why?
| | Animals | 4 | 2015 | 38106 | 0.030 |
Why?
| | Teaching | 1 | 2018 | 244 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2013 | 3125 | 0.030 |
Why?
| | Blotting, Northern | 1 | 2005 | 197 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2013 | 4118 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 778 | 0.030 |
Why?
| | Fatty Acid Desaturases | 1 | 2005 | 32 | 0.030 |
Why?
| | Recovery of Function | 1 | 2019 | 725 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2013 | 1982 | 0.030 |
Why?
| | Arabidopsis Proteins | 1 | 2005 | 78 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2017 | 1298 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1378 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1331 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1543 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 974 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2786 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2014 | 4580 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2017 | 1712 | 0.020 |
Why?
| | Blotting, Western | 1 | 2005 | 1177 | 0.020 |
Why?
| | Middle Aged | 3 | 2019 | 36619 | 0.020 |
Why?
| | Mice | 2 | 2015 | 18297 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 6034 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 2113 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2013 | 541 | 0.020 |
Why?
| | Neurosurgical Procedures | 1 | 2013 | 209 | 0.020 |
Why?
| | Aged | 2 | 2019 | 26432 | 0.020 |
Why?
| | Orthopedics | 1 | 2013 | 182 | 0.020 |
Why?
| | Risk | 1 | 2013 | 920 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2012 | 8391 | 0.020 |
Why?
| | Internet | 1 | 2013 | 660 | 0.020 |
Why?
| | Genotype | 1 | 2013 | 1879 | 0.020 |
Why?
| | Rupture | 1 | 2008 | 91 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5439 | 0.020 |
Why?
| | Risk Assessment | 1 | 2017 | 3712 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2005 | 2791 | 0.020 |
Why?
| | Cohort Studies | 1 | 2017 | 6077 | 0.010 |
Why?
| | Risk Factors | 2 | 2013 | 10921 | 0.010 |
Why?
| | Lipid Metabolism | 1 | 2008 | 533 | 0.010 |
Why?
| | Hemodynamics | 1 | 2008 | 1114 | 0.010 |
Why?
| | Sex Factors | 1 | 2008 | 2107 | 0.010 |
Why?
| | Proteins | 1 | 2008 | 1022 | 0.010 |
Why?
| | Endothelium, Vascular | 1 | 2008 | 952 | 0.010 |
Why?
| | Smoking | 1 | 2008 | 1486 | 0.010 |
Why?
| | Apoptosis | 1 | 2008 | 2439 | 0.010 |
Why?
| | Hypertension | 1 | 2008 | 1272 | 0.010 |
Why?
|
|
Cotter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|